Mohammad Mahdee Sobhanie

This researcher works in infectious diseases medicine, focusing on the treatment and clinical outcomes of bacterial infections such as methicillin-resistant Staphylococcus aureus (MRSA), enterococcal endocarditis (a heart valve infection), and other serious bloodstream and organ infections. Much of the work involves retrospective studies comparing antibiotic treatment strategies, including drugs like daptomycin, vancomycin, ceftaroline, and ertapenem, as well as some COVID-19 treatment outcome studies. The research is largely clinical, drawing on patient case data to inform decisions about antibiotic selection and combination therapy.

Publication output was minimal before 2019, rose sharply to a peak in 2021, and has continued at a moderate, fairly steady pace of about 3-5 papers per year through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026